Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
Join a pioneering organization at the forefront of somatic genomics as a Senior AI/ML Scientist. This role offers the chance to develop innovative machine learning and deep learning methods to tackle significant challenges in genomics. Collaborate with a dynamic team of experts in a vibrant research environment, where your contributions will directly impact drug discovery and healthcare solutions. This innovative firm is dedicated to transforming human health through groundbreaking technologies, providing a unique opportunity for professional growth and collaboration in a supportive atmosphere. If you're passionate about applying AI to life sciences, this is the perfect opportunity for you.
What if… you could join an organization that creates, resources, and builds life sciences companies that invent breakthrough technologies to transform human health and sustainability?
Company Summary:
Quotient Therapeutics, Inc. is a privately held, early-stage company developing a novel genomics platform and therapeutics for diseases with a large unmet need.
Quotient Therapeutics, Inc. was founded by Flagship Pioneering, an innovative enterprise that conceives, creates, resources, and grows first-in-category life sciences companies. Flagship Pioneering has created over 100 groundbreaking companies over the past twenty years, all of which are pioneering novel and proprietary biological, industrial, and engineering approaches to solve major needs in human health and sustainability. These companies include Moderna (MRNA), Generate Biomedicines, Sana Biotechnology (SANA), Tessera Therapeutics, Evelo Biosciences (EVLO), Indigo Agriculture, Seres Therapeutics (MCRB), and Syros Pharmaceuticals (SYRS). To date, Flagship has deployed over $2.5 billion in capital toward the founding and growth of its pioneering companies alongside more than $19 billion of follow-on investments from other institutions. In 2021, Flagship Pioneering was ranked 12th globally on Fortune’s “Change the World” list, an annual ranking of companies that have made a positive social and environmental impact through activities that are part of their core business strategies.
Position Summary:
We are seeking a visionary Senior AI/ML Scientist to be part of ground-breaking research at the forefront of somatic genomics. You will be part of a dynamic team at Quotient’s multidisciplinary research environment comprising AI scientists, computational biologists, genome scientists, software engineers, and disease area specialists. You will also work closely with specialists in translational science, drug discovery, and pre-clinical modelling. In this role, you will be responsible for designing and implementing novel machine learning and deep learning methods applied to somatic genomics. This includes identifying research problems that could be addressed through structured or unstructured, complex omics and imaging data and developing appropriate models and analytical solutions.
Responsibilities:
Key Qualifications:
Additional Preferred Skills:
Location: Cambridge, England
Join Our Innovative Biotech Venture:
At Quotient Therapeutics, we're not just a team; we're pioneers on a mission to revolutionise the biotech landscape. Nestled in the vibrant outskirts of Cambridge, our company is all about innovative thinking and collaborative spirit.
What We Offer:
Flagship Pioneering and our ecosystem companies are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.
Recruitment & Staffing Agencies: Flagship Pioneering and its affiliated Flagship Lab companies (collectively, “FSP”) do not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to FSP or its employees is strictly prohibited unless contacted directly by Flagship Pioneering’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of FSP, and FSP will not owe any referral or other fees with respect thereto.